Lantern Pharma Receives Certificate of Patent from Japanese Patent Office (JPO) for Composition of Matter Covering Drug Candidate LP-284
LP-284 is currently in a Phase 1 clinical trial, having been developed with guidance from Lantern’s AI platform, RADR®, as...

Douvikas hat-trick fuels Como’s record 9-1 demolition of Lens
Guirassy injured as Dortmund host Betis in Champions League
Valverde’s late winner has made his absence the real Real Madrid risk
Oil’s 12% crash is a Washington story, not a supply story
Arsenal beat Slavia Prague 1-0 in Champions League with late own goal 





























